Impact myocardial cytoprotection and inotropic stimulation at the annual prognosis in patients with myocardial infarction lifting segment ST, complicated heart failure

Autor:	T. V Pepelyaeva, A T Teplyakov, M.N. Sin’Kova, F. Yu Mukharlyamov, L. K Isakov, N. I Tarasov
Rok vydání:	2015
Předmět:	Inotrope lcsh:Diseases of the circulatory (Cardiovascular) system medicine.medical_specialty Percutaneous transluminal coronary angioplasty acute myocardial infarction lcsh:Diseases of the endocrine glands. Clinical endocrinology meldonium dihydrate levosimendan Internal medicine medicine In patient cardiovascular diseases Myocardial infarction Meldonium lcsh:RC648-665 business.industry percutaneous transluminal coronary angioplasty Levosimendan medicine.disease Cytoprotection congestive heart failure lcsh:RC666-701 Heart failure Cardiology business medicine.drug
Zdroj:	КардиоСоматика, Vol 6, Iss 2, Pp 30-34 (2015)
ISSN:	2658-5707 2221-7185
DOI:	10.26442/cs45131
Popis:	The article analyzes the effectiveness and safety of treatment cytoprotectant meldonium dihydrate and inotropic stimulator of levosimendan on an annual prognosis in patients with myocardial infarction complicated by acute heart failure II-III class Killip, subjected to percutaneous transluminal coronary angioplasty.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea02abc986e6ab64f1f73a440a1eb905 https://doi.org/10.26442/cs45131 Zobrazit plný text záznamu